Search Results
Jun 30, 2025, 04:21 ET Piramal Pharma Solutions Breaks Ground on $90M Expansion Plan
Limited Piramal Pharma Limited (PPL, NSE: PPLPHARMA I BSE: 543635), offers a portfolio of differentiated products and services through its 17* global development and manufacturing facilities and a global distribution network in over 100 countries. PPL includes Piramal Pharma Solutions (PPS),
More news about: Piramal Pharma Ltd
Jun 30, 2025, 04:10 ET Piramal Pharma Solutions Breaks Ground on $90M Expansion Plan
Limited Piramal Pharma Limited (PPL, NSE: PPLPHARMA I BSE: 543635), offers a portfolio of differentiated products and services through its 17* global development and manufacturing facilities and a global distribution network in over 100 countries. PPL includes Piramal Pharma Solutions (PPS),
More news about: Piramal Pharma Ltd
Jun 23, 2025, 09:00 ET Pasadena Private Lending Surpasses $300 Million in Loans Closed, Underscoring Its Commitment to Entrepreneurial Growth and Long-Term Partnerships
PASADENA, Calif., June 23, 2025 /PRNewswire/ -- Pasadena Private Lending (PPL), a pioneer in the lower middle market lending space, proudly announces it has surpassed $300 million in loans closed since
More news about: Pasadena Private Financial Group
May 30, 2025, 08:00 ET MIB Elects New Chair, Vice Chair, and Directors to its Board
Insurance Company; Dean A. Del Vecchio, Executive Vice President and Chief Technology and Innovation Officer, PPL Corporation; Michael C. S. Fosbury, former President and Chief Executive Officer of Columbian Financial Group; and Dr. Gina
More news about: MIB Group Holdings, Inc.
May 29, 2025, 08:00 ET Simpplr Wins Six Awards, Setting New Standard for AI-Powered Employee Experience Platforms
excellence that Simpplr strives for every day. "These awards reflect not just the power of our platform but also the passion and expertise of our PPL," said Dhiraj Sharma, CEO and Founder of Simpplr. "I'm proud of how our team shows up for our customers and for each other
More news about: Simpplr
May 28, 2025, 08:45 ET Chesapeake Utilities Corporation Appoints Abhijit Bhatwadekar as Chief Information Officer
advance our business transformation goals through innovation and enhanced technology capabilities." Bhatwadekar joins Chesapeake Utilities from PPL Corporation, where he served as vice president of data analytics and customer experience, leading critical initiatives focused on improving customer
More news about: Chesapeake Utilities Corporation
May 16, 2025, 14:31 ET PPL to Pay Quarterly Stock Dividend Jul. 1, 2025
-- PPL Corporation (NYSE: PPL) declared a quarterly common stock dividend on Friday, May 16, 2025, of $0.2725 per share, payable Jul. 1, 2025 to shareowners of record as of Jun.10, 2025. About PPLPPL
More news about: PPL Services Corporation
May 16, 2025, 01:10 ET Piramal Pharma Limited annuncia i risultati del quarto trimestre e dell'anno fiscale 2025
il benessere. Inoltre una delle società associate di PPL, Abbvie Therapeutics India Private Limited, una joint venture tra Abbvie e PPL, si è affermata tra i leader di mercato nell'area della terapia oftalmologica nel settore farmaceutico indiano. PPL inoltre detiene una partecipazione strategica di minoranza
More news about: Piramal Pharma Ltd
May 15, 2025, 17:19 ET Piramal Pharma Limited annonce ses résultats pour le quatrième trimestre et l'exercice 2025
libre. En outre, l'une des entreprises associées de PPL, Abbvie Therapeutics India Private Limited, une coentreprise entre Abbvie et PPL, s'est imposée comme l'un des leaders du marché pharmaceutique indien dans le domaine des thérapies ophtalmologiques. PPL détient un investissement stratégique minoritaire
More news about: Piramal Pharma Ltd
May 15, 2025, 14:25 ET Piramal Pharma Limited gibt Ergebnisse für Q4 und GJ2025 bekannt
hat sich eines der verbundenen Unternehmen von PPL, Abbvie Therapeutics India Private Limited, ein Joint Venture zwischen Abbvie und PPL, als einer der Marktführer im Bereich der Augenheilkunde auf dem indischen Pharmamarkt etabliert. Darüber hinaus hält PPL eine strategische Minderheitsbeteiligung an Yapan
More news about: Piramal Pharma Ltd
May 15, 2025, 11:30 ET LG&E and KU investing in system enhancements for customers
lge-ku.com/assistance. Louisville Gas and Electric Company and Kentucky Utilities Company, part of the PPL Corporation (NYSE: PPL) family of companies, are regulated utilities that serve more than 1.3 million customers and have consistently ranked among the best companies
More news about: LG&E and KU
May 15, 2025, 07:25 ET Piramal Pharma Limited anuncia los resultados del cuarto trimestre y del año fiscal 2025
Además, una de las empresas asociadas de PPL, Abbvie Therapeutics India Private Limited, una empresa conjunta entre Abbvie y PPL, se ha consolidado como uno de los líderes del mercado en el área de terapia oftalmológica en el mercado farmacéutico indio. Asimismo, PPL tiene una inversión minoritaria estratégica
More news about: Piramal Pharma Ltd
May 14, 2025, 14:32 ET Piramal Pharma Limited Announces Results for Q4 and FY2025
Limited: Piramal Pharma Limited (PPL, NSE: PPLPHARMA I BSE: 543635), offers a portfolio of differentiated products and services through its 17* global development and manufacturing facilities and a global distribution network in over 100 countries. PPL includes Piramal Pharma Solutions (PPS),
More news about: Piramal Pharma Ltd
May 14, 2025, 14:26 ET Piramal Pharma Limited Announces Results for Q4 and FY2025
Limited: Piramal Pharma Limited (PPL, NSE: PPLPHARMA I BSE: 543635), offers a portfolio of differentiated products and services through its 17* global development and manufacturing facilities and a global distribution network in over 100 countries. PPL includes Piramal Pharma Solutions (PPS),
More news about: Piramal Pharma Ltd
May 13, 2025, 10:01 ET Piramal Pharma Ltd. continua a investire negli USA con 90 milioni di USD nell'espansione di due siti statunitensi
il benessere. Inoltre una delle società associate di PPL, Abbvie Therapeutics India Private Limited, una joint venture tra Abbvie e PPL, si è affermata tra i leader di mercato nell'area della terapia oftalmologica nel settore farmaceutico indiano. PPL inoltre detiene una partecipazione strategica di minoranza
More news about: Piramal Pharma Ltd
May 13, 2025, 06:38 ET Piramal Pharma Ltd. investiert weiter in den USA; 90 Mio. USD in den Ausbau von zwei US-Standorten
hat sich eines der verbundenen Unternehmen von PPL, Abbvie Therapeutics India Private Limited, ein Joint Venture zwischen Abbvie und PPL, als einer der Marktführer im Bereich der Augenheilkunde auf dem indischen Pharmamarkt etabliert. Darüber hinaus hält PPL eine strategische Minderheitsbeteiligung an Yapan
More news about: Piramal Pharma Ltd
May 13, 2025, 04:40 ET Piramal Pharma Ltd. poursuit ses investissements aux États-Unis : 90 millions de dollars pour l'agrandissement de deux sites américains
libre. En outre, l'une des entreprises associées de PPL, Abbvie Therapeutics India Private Limited, une coentreprise entre Abbvie et PPL, s'est imposée comme l'un des leaders du marché pharmaceutique indien dans le domaine des thérapies ophtalmologiques. PPL détient un investissement stratégique minoritaire
More news about: Piramal Pharma Ltd
May 12, 2025, 16:47 ET Piramal Pharma Ltd. invierte 90 millones de dólares en la expansión de dos plantas en EE.UU.
Además, una de las empresas asociadas de PPL, Abbvie Therapeutics India Private Limited, una empresa conjunta entre Abbvie y PPL, se ha consolidado como uno de los líderes del mercado en el área de terapia oftalmológica en el mercado farmacéutico indio. Asimismo, PPL cuenta con una inversión minoritaria
More news about: Piramal Pharma Ltd
May 12, 2025, 10:16 ET Piramal Pharma Ltd. Continues to Invest In USA; $90M in Expansions of Two US Sites
Limited: Piramal Pharma Limited (PPL, NSE: PPLPHARMA I BSE: 543635), offers a portfolio of differentiated products and services through its 17* global development and manufacturing facilities and a global distribution network in over 100 countries. PPL includes Piramal Pharma Solutions (PPS),
More news about: Piramal Pharma Ltd
May 12, 2025, 10:11 ET Piramal Pharma Ltd. Continues to Invest In USA; $90M in Expansions of Two US Sites
Limited: Piramal Pharma Limited (PPL, NSE: PPLPHARMA I BSE: 543635), offers a portfolio of differentiated products and services through its 17* global development and manufacturing facilities and a global distribution network in over 100 countries. PPL includes Piramal Pharma Solutions (PPS),
More news about: Piramal Pharma Ltd
May 11, 2025, 15:41 ET Concirrus ernennt Branchenspezialist Steve O'Reilly zum Product Manager
Steve bringt eine beeindruckende Erfolgsbilanz in der Branche mit, nachdem er leitende Positionen bei Miller und PPL innehatte. Mit seinem Hintergrund in den Bereichen Underwriting-Strategie, digitale Transformation und Produktentwicklung verfügt er über eine Kombination
More news about: Concirrus
May 11, 2025, 15:38 ET Concirrus nomme Steve O'Reilly, spécialiste du secteur, au poste de responsable des produits
Steve rejoint Concirrus avec une expérience impressionnante dans le secteur, après avoir occupé des postes de direction chez Miller et PPL. Avec une expérience en stratégie de souscription, en transformation numérique et en développement de produits, il apporte un mélange de perspicacité
More news about: Concirrus
May 10, 2025, 12:00 ET Concirrus nombra a Steve O'Reilly, especialista del sector, como director de producto
Steve se incorpora a Concirrus con una trayectoria destacada en el sector, habiendo ocupado puestos directivos en Miller y PPL. Con experiencia en estrategia de suscripción, transformación digital y desarrollo de productos, aporta una combinación de visión comercial e innovación
More news about: Concirrus
May 09, 2025, 12:25 ET Concirrus Appoints Industry Specialist Steve O'Reilly as Product Manager
commercial insurance market. Steve joins Concirrus with an impressive track record across the industry, having held senior positions at Miller and PPL. With a background in underwriting strategy, digital transformation, and product development, he brings a blend of commercial insight and innovation
More news about: Concirrus
May 09, 2025, 12:24 ET Concirrus Appoints Industry Specialist Steve O'Reilly as Product Manager
Steve joins Concirrus with an impressive track record across the industry, having held senior positions at Miller and PPL. With a background in underwriting strategy, digital transformation, and product development, he brings a blend of commercial insight and innovation
More news about: Concirrus